Press release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi
Ein Dokument
mehr
STADA sets standard in Specialty by launching the first medicine authorized in the EU for treating rare kidney disease - Germany is STADA’s lead launch market for EU’s first authorized treatment for a rare kidney disease immunoglobulin A ...